IZKF-Project A73

IZKF

Head of Department:
Prof. Dr. med. André Reis

Checkpoint inhibitors as adjuvants

Checkpoint inhibitors (CPI) show great promise in improving immune control of tumors. However, the co-inhibitory receptors targeted by CPIs also play an important role during the induction of immune responses by viral vaccines. Therefore the aims of the project are to better understand the consequences of CPI therapy on vaccine-induced adaptive immune responses and to explore the potential of CPIs as a systemic and local immunomodulatory vaccine adjuvant.

Prof. Dr. med. Klaus Überla
phone: +49 9131 85-23563
fax: +49 9131 85-22101
e-mail: klaus.ueberla@fau.de
business card
 
Term

01.07.2016 - 30.06.2017

Project Manager

Prof. Dr. Klaus Überla

Institute of Clinical and Molecular Virology

 
 
 
 
Please insert your name and correct email addresses!
X zum Schließen

Summary